Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while ...
Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperfo...
The European Commission's first delivery of mpox vaccines to Congo aims to combat the outbreak, despite challenges in distr...
To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan.
Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Qu...
Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines ...
Bavarian Nordic submits data to European Medicines Agency seeking approval to extend Imvanex vaccine use to adolescents. New tr...
Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization decl...
A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fi...
